CpG-Adjuvanted Virus-like Particle Vaccine Induces Protective Immunity Against Leishmania donovani Infection
The Journal of Infectious Diseases · 2025
DOI: 10.1093/infdis/jiae526 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Keon-Woong Yoon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul. Hauptthemen laut MEDLINE: Leishmaniasis, Visceral, Leishmania donovani, Oligodeoxyribonucleotides, Adjuvants, Immunologic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Core Research Institute Program, Basic Science Research Program, National Research Foundation of Korea.
Abstract (Originalsprache)
Visceral leishmaniasis poses a significant public health challenge due to the lack of an approved human vaccine. We attempted to enhance the efficacy of virus-like particle (VLP) vaccines expressing the Leishmania donovani promastigote surface antigen (LdPSA) by adjuvanting with CpG oligodeoxynucleotide. Here, we evaluated adjuvanted vaccine-induced immune responses and their efficacies in mice challenged with mCherry-expressing L donovani promastigotes. Adjuvanted LdPSA-VLP vaccination significantly elevated parasite-specific IgG serum antibody levels. Additionally, vaccinated mice exhibited enhanced germinal center B cells and splenic T-cell activities as compared with unimmunized mice. Importantly, adjuvanted LdPSA-VLPs reduced the levels of inflammatory cytokines interferon γ and interleukin 6 in visceral organs, leading to decreased total parasite burden and protection against L donovani challenge. Our findings indicate that CpG oligodeoxynucleotide enhanced the protection conferred by LdPSA-VLPs, offering a promising step toward effective visceral leishmaniasis vaccine development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Science, Graduate School, Kyung Hee University, Seoul.
- Department of Parasitology, Inje University College of Medicine.
- Department of Infectious Disease and Malaria, Paik Institute of Clinical Research, Inje University, Busan.
- Department of Medical Zoology, School of Medicine.
- Medical Research Center for Bioreaction to Reactive Oxygen Species and Biomedical Science Institute, Core Research Institute, Kyung Hee University, Seoul, Republic of Korea.
Förderung
- Core Research Institute Program
- Basic Science Research Program
- National Research Foundation of Korea
- Ministry of Education
Zitieren
APA
Yoon, K. W., Chu, K. B., Eom, G. D., Mao, J., Moon, E. K., Kim, S. S., & Quan, F. S. (2025). CpG-Adjuvanted Virus-like Particle Vaccine Induces Protective Immunity Against Leishmania donovani Infection. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae526
Vancouver
Yoon KW, Chu KB, Eom GD, Mao J, Moon EK, Kim SS, et al. CpG-Adjuvanted Virus-like Particle Vaccine Induces Protective Immunity Against Leishmania donovani Infection. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiae526
BibTeX
@article{Yoon2025,
author = {Yoon, Keon-Woong and Chu, Ki Back and Eom, Gi-Deok and Mao, Jie and Moon, Eun-Kyung and Kim, Sung Soo and Quan, Fu-Shi},
title = {CpG-Adjuvanted Virus-like Particle Vaccine Induces Protective Immunity Against Leishmania donovani Infection},
journal = {The Journal of Infectious Diseases},
year = {2025},
doi = {10.1093/infdis/jiae526}
}
EUVIMED